Advertisement
Banner Health Children

Roche's lung cancer combo treatment wins FDA approval

Dec 07, 2018 , Reuters
Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer.


Read the full story...


Trending healthcare news keywords at this moment

blood drug risk study million flu shot americans doctors year illness kids adults tip fda patients mental care home disease healthcare opioid hospital cancer people heart test tied breast opioids state ceo hospitals amp women